Effect of intrapulmonary heparin on plasma diamine oxidase (histaminase) activity in mice

1981 ◽  
Vol 11 (4) ◽  
pp. 335-338 ◽  
Author(s):  
J. Mahadoo ◽  
C. J. Wright ◽  
L. B. Jaques
1962 ◽  
Vol 11 (7) ◽  
pp. 509-514 ◽  
Author(s):  
C. De Marco ◽  
B. Mondoví ◽  
D. Cavallini

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Armelle Tchoumi Neree ◽  
Rodolphe Soret ◽  
Lucia Marcocci ◽  
Paola Pietrangeli ◽  
Nicolas Pilon ◽  
...  

AbstractExcess of histamine in gut lumen generates a pronounced gastrointestinal discomfort, which may include diarrhea and peristalsis dysfunctions. Deleterious effects of histamine can be alleviated with antihistamine drugs targeting histamine receptors. However, many antihistamine agents come with various undesirable side effects. Vegetal diamine oxidase (vDAO) might be a relevant alternative owing to its histaminase activity. Mammalian intestinal mucosa contains an endogenous DAO, yet possessing lower activity compared to that of vDAO preparation. Moreover, in several pathological conditions such as inflammatory bowel disease and irritable bowel syndrome, this endogenous DAO enzyme can be lost or inactivated. Here, we tested the therapeutic potential of vDAO by focusing on the well-known effect of histamine on gut motility. Using ex vivo and in vitro assays, we found that vDAO is more potent than commercial anti-histamine drugs at inhibiting histamine-induced contraction of murine distal colon muscles. We also identified pyridoxal 5′-phosphate (the biologically active form of vitamin B6) as an effective enhancer of vDAO antispasmodic activity. Furthermore, we discovered that rectally administered vDAO can be retained on gut mucosa and remain active. These observations make administration of vDAO in the gut lumen a valid alternative treatment for histamine-induced intestinal dysfunctions.


1992 ◽  
Vol 35 (3-4) ◽  
pp. 192-199 ◽  
Author(s):  
G. Ignesti ◽  
G. Banchelli ◽  
L. Raimondi ◽  
R. Pirisino ◽  
F. Buffoni

1978 ◽  
Vol 8 (4) ◽  
pp. 388-389 ◽  
Author(s):  
A. Fogel ◽  
T. Biegański ◽  
J. Wozniak ◽  
Cz. Máslinski

1978 ◽  
Vol 27 (8) ◽  
pp. 1159-1162 ◽  
Author(s):  
Wieslawa Agnieszka Fogel ◽  
Tadeusz Biegański ◽  
Janina Woz'niak ◽  
Czeslaw Maśliński

1967 ◽  
Vol 15 (8) ◽  
pp. 431-435 ◽  
Author(s):  
RONALD E. GUNTHER ◽  
DAVID GLICK

The spectrophotometric method for determination of histaminase, based on measurement of the hydrogen peroxide formed by the enzymatic oxidation of histamine, was modified and adapted to studies on microliter volumes of tissue (placenta) homogenates and microtome sections of tissue (human uterus and attached intact placenta at term). Optimal conditions for these assays were established. From analyses of tissue sections, peak enzyme activities were observed in the decidua, thus supporting the concept that this tissue is a significant source of the increased enzyme in blood plasma during pregnancy in the human. Inhibitor studies with aminoguanidine sulfate showed that the histaminase investigated in the human placenta was diamine oxidase. No histaminase activity was detected in isolated peritoneal mast cells from the rat or in homogenates of rat stomach mucosa.


Sign in / Sign up

Export Citation Format

Share Document